123 related articles for article (PubMed ID: 38626700)
1. A prognostic model built on amino acid metabolism patterns in HPV-associated head and neck squamous cell carcinoma.
Jing F; Zhu L; Bai J; Zhou X; Sun L; Zhang H; Li T
Arch Oral Biol; 2024 Jul; 163():105975. PubMed ID: 38626700
[TBL] [Abstract][Full Text] [Related]
2.
Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
4. TLR9 Mediated Tumor-Stroma Interactions in Human Papilloma Virus (HPV)-Positive Head and Neck Squamous Cell Carcinoma Up-Regulate PD-L1 and PD-L2.
Baruah P; Bullenkamp J; Wilson POG; Lee M; Kaski JC; Dumitriu IE
Front Immunol; 2019; 10():1644. PubMed ID: 31379843
[No Abstract] [Full Text] [Related]
5. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
[TBL] [Abstract][Full Text] [Related]
6. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.
An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y
Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296
[TBL] [Abstract][Full Text] [Related]
7. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
8. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
[TBL] [Abstract][Full Text] [Related]
10. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.
Abi-Raad R; Prasad ML; Gilani S; Garritano J; Barlow D; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):394-404. PubMed ID: 33369885
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
13. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
14. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
15. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
16. Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study.
Wang WL; Jiang HJ; Shen ZL; Tang YL; Jiang J; Liang XH
Arch Oral Biol; 2024 Jul; 163():105982. PubMed ID: 38678878
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.
Sanchez-Canteli M; Granda-Díaz R; Del Rio-Ibisate N; Allonca E; López-Alvarez F; Agorreta J; Garmendia I; Montuenga LM; García-Pedrero JM; Rodrigo JP
Cancer Immunol Immunother; 2020 Oct; 69(10):2089-2100. PubMed ID: 32448984
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of B lymphocyte infiltration in HPV
Zhang S; Wang B; Ma F; Tong F; Yan B; Liu T; Xie H; Song L; Yu S; Wei L
Cancer Sci; 2021 Apr; 112(4):1402-1416. PubMed ID: 33529452
[TBL] [Abstract][Full Text] [Related]
19. Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.
Payabvash S; Chan A; Jabehdar Maralani P; Malhotra A
Neuroradiol J; 2019 Aug; 32(4):232-240. PubMed ID: 31084347
[TBL] [Abstract][Full Text] [Related]
20. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]